CIN - 医索

找到约 358 条结果

First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma a randomized, double-blind phase 3 trial

医客学院 - 药物研究

Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma An Open-Label, Single-Arm, Phase II Study

医客学院 - 药物研究

Zanidatamab + chemotherapy as first-line treatment for HER2-expressing metastatic gastroesophageal adenocarcinoma (mGEA)

医客学院 - 会议报告集

Tislelizumab versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma Impact on health-related quality

医客学院 - 会议报告集

Real world data of systemic therapy for hepatocellular carcinoma in Japan HERITAGE study

医客学院 - 会议报告集

Phase II study of FGFR1-3 inhibitor tinengotinib as monotherapy in patients with advanced or metastatic cholangiocarcinoma Interim a

医客学院 - 会议报告集

Neo-AEGIS (Neoadjuvant Trial in Adenocarcinoma of the Esophagus and Esophago-Gastric Junction International Study) Final primary out

医客学院 - 会议报告集

HERIZON A phase 2 study of HER-Vaxx (IMU-131), a HER2-targeting peptide vaccine

医客学院 - 会议报告集

Genomic profiling of rare undifferentiated sarcomatoid subtypes of pancreatic carcinomas for potential response to immunotherapy

医客学院 - 会议报告集

First-line lenvatinib plus pembrolizumab plus chemotherapy versus chemotherapy in advancedmetastatic gastroesophageal adenocarcinoma

医客学院 - 会议报告集

今日实时热搜